ILUMYA® Tildrakizumab-asmn 100 mg / mL Injection 1 mL

Name: Interleukin-23 Antagonist
Brand: ILUMYA®

ILUMYA, PFS 100MG/ML

McKesson #

1194226

Manufacturer #

47335017795

Brand

ILUMYA®

Manufacturer

Sun Pharmaceutical Industries Inc

Country of Origin

Unknown

Application

Interleukin-23 Antagonist

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Name

Tildrakizumab-asmn

NDC Number

47335017795

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

100 mg / mL

Type

Subcutaneous

UNSPSC Code

51241200

Volume

1 mL

Indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
Injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution